跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Montair - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Montair
Approved
STANDARD
Montair
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a8658b8faf422b87
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
a8658b8faf422b87
Drug Approval Philippines Name
Montair
Product Name
Montair
Registration Number
DRP-7135
Brand Name
Montair
Generic Name
Montelukast (As Sodium)
Dosage Form
Chewable Tablet
Dosage Strength
5 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Innogen Pharmaceuticals, Inc.
Issuance Date
28 November 2022
Expiry Date
05 December 2027
Pharmacologic Category
Anti-Asthma (Leukotriene Receptor Antagonist)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a8658b8faf422b87
Type
Standard
Back to Philippines FDA Approvals